Cargando…
Prasugrel for the treatment of patients with acute coronary syndrome
Prasugrel (CS-747, LY640315) is a novel member of the thienopyridine class of oral anti-platelet agents (also including ticlopidine and clopidogrel). Like other thienopyridines, prasugrel is a prodrug that is inactive in vitro. Prasugrel’s conversion to its active metabolite is more rapid and effici...
Autores principales: | Marzot, Filippo, Pengo, Vittorio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672466/ https://www.ncbi.nlm.nih.gov/pubmed/19436677 |
Ejemplares similares
-
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009) -
Treating patients suffering from acute coronary syndrome with prasugrel, the Rotterdam experience
por: de Winter, R. J.
Publicado: (2018) -
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
por: Koch, Tobias, et al.
Publicado: (2023) -
Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021) -
Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function
por: Yun, Jun Pil, et al.
Publicado: (2023)